These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38882119)

  • 1. The Rise of Bacterial G-Quadruplexes in Current Antimicrobial Discovery.
    Ciaco S; Aronne R; Fiabane M; Mori M
    ACS Omega; 2024 Jun; 9(23):24163-24180. PubMed ID: 38882119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlocking G-Quadruplexes as Antiviral Targets.
    Abiri A; Lavigne M; Rezaei M; Nikzad S; Zare P; Mergny JL; Rahimi HR
    Pharmacol Rev; 2021 Jul; 73(3):897-923. PubMed ID: 34045305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structurally diverse G-quadruplexes as the noncanonical nucleic acid drug target for live cell imaging and antibacterial study.
    Zheng BX; Yu J; Long W; Chan KH; Leung AS; Wong WL
    Chem Commun (Camb); 2023 Feb; 59(11):1415-1433. PubMed ID: 36636928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance: from basic science to translational innovation.
    Lin J
    Anim Health Res Rev; 2017 Dec; 18(2):85-86. PubMed ID: 29665886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-Quadruplexes in the Viral Genome: Unlocking Targets for Therapeutic Interventions and Antiviral Strategies.
    Pathak R
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-Quadruplexes: More Than Just a Kink in Microbial Genomes.
    Saranathan N; Vivekanandan P
    Trends Microbiol; 2019 Feb; 27(2):148-163. PubMed ID: 30224157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.
    Dhingra S; Rahman NAA; Peile E; Rahman M; Sartelli M; Hassali MA; Islam T; Islam S; Haque M
    Front Public Health; 2020; 8():535668. PubMed ID: 33251170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Strategies to Combat the Emerging Drug Resistance in Human Pathogenic Microbes.
    Qadri H; Shah AH; Mir M
    Curr Drug Targets; 2021; 22(12):1424-1436. PubMed ID: 33371847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crisis averted: a world united against the menace of multiple drug-resistant superbugs -pioneering anti-AMR vaccines, RNA interference, nanomedicine, CRISPR-based antimicrobials, bacteriophage therapies, and clinical artificial intelligence strategies to safeguard global antimicrobial arsenal.
    Saeed U; Insaf RA; Piracha ZZ; Tariq MN; Sohail A; Abbasi UA; Fida Rana MS; Gilani SS; Noor S; Noor E; Waheed Y; Wahid M; Najmi MH; Fazal I
    Front Microbiol; 2023; 14():1270018. PubMed ID: 38098671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlocking G-Quadruplexes as Targets and Tools against COVID-19.
    Qin G; Zhao C; Yang J; Wang Z; Ren J; Qu X
    Chin J Chem; 2022 Dec; ():. PubMed ID: 36711116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in G-quadruplexes-based fluorescent imaging.
    Han JN; Ge M; Chen P; Kuang S; Nie Z
    Biopolymers; 2022 Dec; 113(12):e23528. PubMed ID: 36444749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial Nanomaterials: Mechanisms, Impacts on Antimicrobial Resistance and Design Principles.
    Xie M; Gao M; Yun Y; Malmsten M; Rotello VM; Zboril R; Akhavan O; Kraskouski A; Amalraj J; Cai X; Lu J; Zheng H; Li R
    Angew Chem Int Ed Engl; 2023 Apr; 62(17):e202217345. PubMed ID: 36718001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
    Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring medical and veterinary student perceptions and communication preferences related to antimicrobial resistance in Ontario, Canada using qualitative methods.
    Primeau CA; McWhirter JE; Carson C; McEwen SA; Parmley EJ
    BMC Public Health; 2023 Mar; 23(1):483. PubMed ID: 36915074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Antimicrobial Resistance (AMR) and Alternative Approaches to Overcome AMR.
    Moo CL; Yang SK; Yusoff K; Ajat M; Thomas W; Abushelaibi A; Lim SH; Lai KS
    Curr Drug Discov Technol; 2020; 17(4):430-447. PubMed ID: 30836923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Resistance.
    Marston HD; Dixon DM; Knisely JM; Palmore TN; Fauci AS
    JAMA; 2016 Sep; 316(11):1193-1204. PubMed ID: 27654605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance: A global emerging threat to public health systems.
    Ferri M; Ranucci E; Romagnoli P; Giaccone V
    Crit Rev Food Sci Nutr; 2017 Sep; 57(13):2857-2876. PubMed ID: 26464037
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.